Home › ARK DIAGNOSTICS INC › ARK™ Methotrexate II Control
ARK™ Methotrexate II Control
ARK DIAGNOSTICS INC · Model 5071-0003-02 · UDI-DI 00812101031216
LAO
Prescription
1
510(k) clearances
20
Adverse events
2
Recalls
4
Facilities
Description
ARK™ Methotrexate II Control is intended for use in quality control of the ARK Methotrexate II Assay.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2016-03-08 | Siemens Healthcare Diagnostics, Inc. | Siemens Healthcare Diagnostics confirmed that Syva Emit Methotrexate Application (DVMTX.1) for Dimension Vista System does not meet On-Board Stability claim of 20 hours. Testing us |
| 2007-03-20 | Abbott Diagnostic International, Ltd. | Incorrect configuration: kits contain reagent bottles in the order S-W-T-P instead of the correct order, W-S-T-P. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.